| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2012 | US20120004254 G protein-coupled receptor antagonist and its use for preventing and treating alzheimer's disease |
| 01/05/2012 | US20120004253 Novel Fused Pyrrolocarbazoles |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004251 Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy |
| 01/05/2012 | US20120004250 Pyrimidine classical cannabinoid compounds and related methods of use |
| 01/05/2012 | US20120004249 The polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 01/05/2012 | US20120004248 Methods of using a methylxanthine compound |
| 01/05/2012 | US20120004247 Organic compounds |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004245 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004243 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/05/2012 | US20120004242 Oligomer-Diarylpiperazine Conjugates |
| 01/05/2012 | US20120004241 Succinate salt of (2r)-methyl-1-piperazine |
| 01/05/2012 | US20120004240 Inhibitors of akt activity |
| 01/05/2012 | US20120004239 Process for Preparing Quinoxaline Derivatives |
| 01/05/2012 | US20120004238 L-methylfolate treatment for psychiatric or neurologic disorders |
| 01/05/2012 | US20120004237 Salt of cd 80 antagonist |
| 01/05/2012 | US20120004236 Substituted triazolo-pyridazine derivatives |
| 01/05/2012 | US20120004235 Methods to treat cancer |
| 01/05/2012 | US20120004234 Phthalazine-containing antidiabetic compounds |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004232 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative |
| 01/05/2012 | US20120004231 Substituted Pyridazine Derivatives |
| 01/05/2012 | US20120004230 Imidazole derivatives |
| 01/05/2012 | US20120004229 Substituted diketopiperazines and their use as oxytocin antagonists |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004227 Cyclohexane derivative having npy y5 receptor antagonism |
| 01/05/2012 | US20120004226 Modulators of Muscarinic Receptors |
| 01/05/2012 | US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004223 Compounds, compositions and methods for reducing lipid levels |
| 01/05/2012 | US20120004222 Cb2 receptor ligands for the treatment of pain |
| 01/05/2012 | US20120004221 Antibacterial Compositions |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004219 Method of Inhibition of Respiratory Depression Using Positive Allosteric AMPA Receptor Modulators |
| 01/05/2012 | US20120004218 Novel tetrahydro-quinoline derivatives |
| 01/05/2012 | US20120004217 Therapeutic agents useful for treating pain |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004213 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 01/05/2012 | US20120004212 Organic compounds |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004209 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
| 01/05/2012 | US20120004208 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/05/2012 | US20120004205 Il-13 induced gene signature for eosinophilic esophagitis |
| 01/05/2012 | US20120004204 Methods for treating sexual dysfunction while decreasing cardiovascular risk |
| 01/05/2012 | US20120004203 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 01/05/2012 | US20120004202 Medicaments for the treatment or prevention of fibrotic diseases |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120004200 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/05/2012 | US20120004199 Scaffolds |
| 01/05/2012 | US20120004198 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 01/05/2012 | US20120004197 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient |
| 01/05/2012 | US20120004196 Anti-Viral Compounds |
| 01/05/2012 | US20120004195 Cyclodextrin-based polymers for therapeutic delivery |
| 01/05/2012 | US20120004194 Aldehyde-functionalized polysaccharides |
| 01/05/2012 | US20120004193 Process for production of orally ingestible composition containing arabinofuranosyl vitexin, and use of the composition |
| 01/05/2012 | US20120004192 Use of lactulose in the treatment of autism |
| 01/05/2012 | US20120004191 Combinational Compositions And Methods For Treatment Of Cancer |
| 01/05/2012 | US20120004190 Heterobifunctional pan-selectin inhibitors |
| 01/05/2012 | US20120004189 Compositions and products containing s-equol, and methods for their making |
| 01/05/2012 | US20120004188 Use of ranolazine for treating pulmonary hypertension |
| 01/05/2012 | US20120004187 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004177 Compositions and methods of delivery of pharmacological agents |
| 01/05/2012 | US20120004175 Inhibitors of nf-kb activity |
| 01/05/2012 | US20120004172 Screening method of anti-lung or esophageal cancer compounds |
| 01/05/2012 | US20120004171 Novel therapies for chronic renal failure |
| 01/05/2012 | US20120004169 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 01/05/2012 | US20120004167 (2-aryloxyacetylamino) phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004166 Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004164 Organic compounds |
| 01/05/2012 | US20120004162 Methods of Treating an Overweight or Obese Subject |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120004158 Quaternised Ammonium Cyclodextrin Compounds |
| 01/05/2012 | US20120004157 Hydroxyproline compositions and uses thereof |
| 01/05/2012 | US20120003367 Dietary fiber composition |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003335 Constitutive androstane receptor (car) as a therapeutic target for obesity and type two diabetes |
| 01/05/2012 | US20120003330 Benzoquinolone inhibitors of vmat2 |
| 01/05/2012 | US20120003329 Use of A2B Adenosine Receptor Antagonists for Treating Pulmonary Hypertension |
| 01/05/2012 | US20120003327 Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 01/05/2012 | US20120003321 Crosslinked Dextran Composite Magnetic Microparticles and Preparation Process and Using Method Thereof |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003319 Compositions for site-specific delivery of imatinib and methods of use |
| 01/05/2012 | US20120003318 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| 01/05/2012 | US20120003316 Transmucosal delivery system |
| 01/05/2012 | US20120003314 Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
| 01/05/2012 | US20120003313 Dpp iv inhibitor formulations |
| 01/05/2012 | US20120003312 Multilayer Minitablets with Different Release Rates |
| 01/05/2012 | US20120003311 Method for controlled release of an acid-unstable physiologically active substance |
| 01/05/2012 | US20120003310 Delayed release rasagiline formulation |
| 01/05/2012 | US20120003309 Solid Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003308 Pharmaceutical Composition Comprising Aliskiren |